Oncology distributor implements tracking system
US Oncology, a cancer treatment and research network that also acts as a distributor, is implementing an electronic pedigree data management solution.
US Oncology, a cancer treatment and research network that also acts as a distributor, is implementing an electronic pedigree data management solution. With the technology, US Oncology hopes to ensure that every drug distributed through its network is protected with the ePedigree track-and-trace system that documents the drug's history in the distribution channel. US Oncology launched its pharmaceutical distribution business in 2005 and issues and delivers more than $1.8 billion in drugs throughout its network. The ePedigree tracks the path of each oncology drug through the supply chain and verifies the information. US Oncology is one of the first distributors to earn NABP's Verified-Accredited Wholesale Distributors (VAWD) accreditation
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
